Blockchain Registration Transaction Record

HeartBeam Enrolls First Patients in Groundbreaking Heart Attack Detection Study

HeartBeam begins ALIGN-ACS study for heart attack detection using its FDA-cleared 3D ECG technology. Medical breakthrough enables portable cardiac monitoring outside hospitals.

This development matters because heart attacks remain a leading cause of death worldwide, often with delayed diagnosis that worsens outcomes. Current ECG technology typically requires hospital settings and trained technicians, creating barriers to timely detection. HeartBeam's portable 3D ECG system could revolutionize cardiac care by enabling accurate heart attack detection anywhere—at home, at work, or in ambulances—potentially saving thousands of lives through earlier intervention. For patients with cardiac risk factors, this technology promises greater peace of mind and potentially life-saving early warnings. For healthcare systems, it could reduce emergency room overcrowding and hospital costs while improving cardiac outcomes. The technology's expansion from arrhythmia to heart attack detection represents a significant advancement in telemedicine and remote patient monitoring, aligning with broader trends toward decentralized healthcare delivery.